These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14602869)

  • 1. Assessment of treatment response by autoradiography with (14)C-aminocyclopentane carboxylic acid, (67)Ga-DTPA, and (18)F-FDG in a herpes simplex virus thymidine kinase/ganciclovir brain tumor model.
    Miyagawa T; Oku T; Sasajima T; Dasai R; Beattie B; Finn R; Tjuvajev JG; Blasberg R
    J Nucl Med; 2003 Nov; 44(11):1845-54. PubMed ID: 14602869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
    Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Facilitated" amino acid transport is upregulated in brain tumors.
    Miyagawa T; Oku T; Uehara H; Desai R; Beattie B; Tjuvajev J; Blasberg R
    J Cereb Blood Flow Metab; 1998 May; 18(5):500-9. PubMed ID: 9591842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.
    Haberkorn U; Altmann A; Morr I; Germann C; Oberdorfer F; van Kaick G
    J Nucl Med; 1997 Jul; 38(7):1048-54. PubMed ID: 9225789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
    Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
    J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain.
    Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
    Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging.
    Namba H; Iwadate Y; Tagawa M; Kimura M; Shimizu H; Sato Y; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1996 Oct; 7(15):1847-52. PubMed ID: 8894676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
    Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.